Knie Robb has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 800000 shares of Hoth Therapeutics, Inc. ($HOTH) on August 27, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 27, 2025 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | A | Common Stock | 800000 | $0.00 | 858,131.0000 | 13,180,243 | 1376.20% | 6.07% |
| Aug. 28, 2025 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | F | Common Stock | 310744 | $1.21 | 547,387.0000 | 13,180,243 | 36.21% | 2.36% |
| Jan. 14, 2025 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | A | Options | 7000 | $0.00 | 7,000.0000 | 6,375,161 | 9999.99% | 0.11% |
| Jan. 14, 2025 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | A | Options | 93000 | $0.00 | 93,000.0000 | 6,375,161 | 9999.99% | 1.46% |
| Aug. 19, 2024 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | A | Options | 325000 | $0.00 | 325,000.0000 | 6,876,331 | 9999.99% | 4.73% |
| Aug. 16, 2024 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | P | Common Stock | 25000 | $0.67 | 58,131.0000 | 6,876,331 | 75.46% | 0.36% |
| Jan. 5, 2024 | Hoth Therapeutics, Inc. | $HOTH | Knie Robb | CEO and President | A | Options | 225000 | $0.00 | 225,000.0000 | 3,409,190 | 9999.99% | 6.60% |